Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

DuPont Merck presents dual MMP/TNF-alpha-converting enzyme inhibitor

Sep. 12, 1997

RWJ-63556: dual COX-2/5-LO inhibitor effective in canine model of local inflammation

Sep. 12, 1997

IDEC licenses rights to novel antiinflammatory technology

Sep. 11, 1997

New hydroxamic acid compounds inhibiting TNF, PDE IV and/or MMPs

Sep. 11, 1997

Promising preliminary results obtained with Arthrovas in osteoarthritis

Sep. 10, 1997

Boehringer Mannheim prepares MMP inhibitors

Sep. 8, 1997

Anika completes phase III trial on Orthovisc

Sep. 4, 1997

New MMP and TNF inhibitor from Kanebo

Sep. 2, 1997

Hyalgan introduced in U.S. for osteoarthritis of the knee

Sep. 1, 1997

Pharos receives patent for novel method of controlling and treating inflammation

Aug. 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...